- Home
- Publications
- Publication Search
- Publication Details
Title
Global experience with ixabepilone in breast cancer
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 11, Issue 5, Pages 683-692
Publisher
Informa UK Limited
Online
2011-05-10
DOI
10.1586/era.11.41
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes
- (2010) Gabriel N. Hortobagyi et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
- (2010) Edith A. Perez et al. BREAST CANCER RESEARCH AND TREATMENT
- African ancestry and higher prevalence of triple-negative breast cancer
- (2010) Azadeh Stark et al. CANCER
- Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment
- (2010) Jiayu Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Clinical Characteristics and Outcome of Treatment of Brazilian Women with Breast Cancer Treated at Public and Private Institutions – The AMAZONE Project of the Brazilian Breast Cancer Study Group (GBECAM).:
- (2010) S. Simon et al. CANCER RESEARCH
- Breast Cancer Classification According to Immunohistochemistry Markers: Subtypes and Association With Clinicopathologic Variables in a Peruvian Hospital Database
- (2010) Carlos S. Vallejos et al. Clinical Breast Cancer
- Supporting Asian patients with metastatic breast cancer during ixabepilone therapy
- (2010) Laura Bourdeanu et al. Expert Opinion On Drug Safety
- Prognostic Significance of 18q Loss of Heterzygosity in Microsatellite-Stable Colorectal Cancer
- (2010) Toshiaki Watanabe et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Ixabepilone Plus Capecitabine Versus Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2010) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial
- (2009) Stacy Moulder et al. BREAST CANCER RESEARCH AND TREATMENT
- Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer
- (2009) Xavier B. Pivot et al. EUROPEAN JOURNAL OF CANCER
- Ethnic differences in drug metabolism and toxicity from chemotherapy
- (2009) Viet Hong Phan et al. Expert Opinion on Drug Metabolism & Toxicology
- The Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Ixabepilone: A First in Class Epothilone B Analogue in Late-Phase Clinical Development
- (2008) S. Goel et al. CLINICAL CANCER RESEARCH
- Individual Genomes Instead of Race for Personalized Medicine
- (2008) PC Ng et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines
- (2008) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
- (2008) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Development of Ixabepilone and Other Epothilones in Patients with Advanced Solid Tumors
- (2008) E. Rivera et al. ONCOLOGIST
- The Implications of Population Admixture in Race-based Drug Prescription
- (2007) G Suarez-Kurtz CLINICAL PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More